Title
FAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute Psychosis
Phase
Phase 3Lead Sponsor
AstraZenecaStudy Type
InterventionalStatus
TerminatedIndication/Condition
Psychotic Disorders Schizophrenia Bipolar DisorderIntervention/Treatment
quetiapine ...Study Participants
NoneThe purpose of this study is to compare the efficacy of quetiapine IR, following rapid titration versus conventional titration in patients with acute psychosis
Inclusion Criteria: provision of written informed consent male or female, aged 18-65 years requirement of hospitalization and in need for antipsychotic treatment for an acute psychotic episode able to swallow tablets from Day 1 Exclusion Criteria: In-patients who are anticipated to be discharged before evaluation of the primary outcome variable at Day 5 patients with known relevant clinical disease history of syncope, or orthostatic hypotension patients with known neutropenia